NASDAQ: ABEO · Biotechnology
Over the past week, Abeona Therapeutics (ABEO) saw about 40 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 36% bullish across the tracked sources. Wall Street is more constructive, with 6 of 6 analysts rating ABEO a buy.
There is little buzz around ABEO this week and broad agreement on direction, which is why it reads as a Sell.
Wall Street’s 100% buy share sits next to a crowd that ranges from News at 30% to X at 46%. No other tracker puts the two side by side.
6 analysts have weighed in: a Strong Buy consensus: 6 buy calls against 0 sell, with an average 12-month price target of $19.71.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is cooling and the 3 sources only partly agree, so the read is a Sell.
Analysts sit 64 points above the crowd average of 36%, the professionals are more constructive than retail. The split is inside the crowd: X reads 46% bullish while News sits at 30%, a 16-point spread that single-source trackers miss.
Over the 30-day window, Abeona Therapeutics (ABEO) buzz held moderate around 42.3 while the price drifted down 14.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.6M shares. Updated Aug 15, 2026. Over the last 7 trading days, ABEO lost 13.3%. Buzz activity in the recent week averaged 33.3 and was variable, swinging between 21.8 and 42.3. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 5 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ABEO and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ABEO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (6 / 0 / 0) |
| Crowd bullish (7d) | 36% |
| Avg price target | $19.71 |
| Most bullish source | X, 46% |
| Most bearish source | News, 30% |
| Sentiment spread | 16 pts |
| Mentions (7d) | 40 |
| Market cap | $361.6M |
| P/E · Forward P/E | n/a · 526.3 |
| EPS · Beta | -$1.21 · 1.3 |
| Revenue (TTM) | $25.5M · -246% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Abeona Therapeutics (ABEO) currently carries an Adanos sell signal with 93/100 conviction. The current cross-source average reads 36% bullish across 3 active sources. Those sources contribute 40 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Abeona Therapeutics (ABEO) is fairly quiet with 6 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads bearish on Abeona Therapeutics (ABEO), averaging 36% bullish across 3 tracked sources over the last 7 days. The two ends of the range are X at 46% bullish and News at 30%, a 16-point spread. On the professional side, 6 of 6 analysts rate ABEO a buy.
Of the 6 analysts covering Abeona Therapeutics (ABEO), 6 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $19.71. That puts the street ahead of the crowd, which averages 36% bullish.
Abeona Therapeutics (ABEO)'s cross-source average is bearish at 36% bullish. All 3 tracked sources lean bearish. Reddit reads 33% bullish, X reads 46% bullish and news coverage is the most negative at 30% bullish. The combined signal points to broad sell-side pressure with 93/100 conviction.
The cross-source average is bearish for Abeona Therapeutics (ABEO) at 36% bullish. All 3 tracked sources lean bearish. The most bearish reading is news at 30% bullish. 3-day activity momentum is falling across Reddit and X and News. The sell signal carries 93/100 conviction.
X is the dominant discussion channel with 24 mentions (60% of total volume). News contributes 10 mentions and Reddit contributes 6 mentions. The cross-source average is bearish at 36% bullish. All 3 tracked sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ABEO's sell signal at 93/100 conviction reflects a bearish cross-source average at 36% bullish. All 3 tracked sources lean bearish. It is a research shortcut, not financial advice.
The ABEO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key